 |
PDBsum entry 1rkw
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
1rkw
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
279:14365-14371
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structures of QacR-diamidine complexes reveal additional multidrug-binding modes and a novel mechanism of drug charge neutralization.
|
|
D.S.Murray,
M.A.Schumacher,
R.G.Brennan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The Staphylococcus aureus multidrug-binding protein QacR represses transcription
of the plasmid-encoded membrane protein QacA, a multidrug efflux transporter.
QacR is induced by multiple structurally dissimilar monovalent and bivalent
cationic lipophilic compounds, many of which are effluxed from the cell by QacA
via the proton motive force. The multidrug-binding pocket of QacR has been shown
to be quite extensive and features several glutamates and multiple aromatic
residues. To date, the structure of only one QacR-bivalent cationic drug complex
(that of QacR bound to dequalinium) has been determined, and how other longer or
shorter bivalent cationic compounds bind is unknown. Here we report the crystal
structures of QacR bound to two cytotoxic bivalent diamidines, pentamidine and
hexamidine. These compounds are structurally similar, differing by only one
methylene carbon in the alkyl chain linker. However, this small difference
results in very dissimilar binding modes. Similar to dequalinium, hexamidine
spans the multidrug-binding pocket, and its positively charged benzamidine
groups are neutralized by residues Glu-57 and Glu-120. Pentamidine binds QacR in
a novel fashion whereby one of its benzamidine groups interacts with residue
Glu-63, and the other is neutralized by carbonyl and side chain oxygen atoms.
Thus, these structures demonstrate that a formal negative charge is not a
prerequisite for binding positively charged drugs and underscore the versatility
of the QacR and, likely, all multidrug-binding pockets.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
FIG. 4. Stereoview of the pentamidine-QacR-binding pocket.
For clarity, the side chains of only selected residues are shown
(not shown are residues Leu-54, Lys-60, and Gln-96) as sticks,
whereby oxygen atoms are red, nitrogens are blue, carbons are
gray, and the backbone of the drug-bound subunit is aquamarine
with germane helices labeled in blue. Solvent molecules within
the hydrogen-bonding distance of the protein or drug are shown
as red spheres. The hydrogen-bonding network between W1, W2, and
QacR is depicted with black dashed lines. W1 is 3.1 Å from
the hydroxyl oxygen of residue Tyr-93, 3.4 Å from the
hydroxyl of Tyr-123, and 2.8 Å from W2; W2 is
hydrogen-bonded to the hydroxyl oxygen of residue Y123 (2.5
Å) and the backbone carbonyl oxygen of residue L54 (2.9
Å); W3 engages in a weak hydrogen bond with residue
Asn-157 (3.6 Å), and van der Waals contacts with the
pentamidine phenyl ring (closest approach 3.4 Å). The
binding pocket subsites, Site 1 and Site 2, are labeled.
|
 |
Figure 5.
FIG. 5. Close up stereoview of the Site 1 drug-binding site
of pentamidine. Interaction distances are given in angstrom.
Hydrogen bonds are depicted by red dashed lines, van der Waals
contacts are depicted by a black dashed line, a -cation
interaction is depicted by a green dashed line, and stacking
interactions (closest contact) are depicted by purple dashed
lines. Note that no negatively charged side chains are found
within 6 Å of either of the amidinic nitrogens.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2004,
279,
14365-14371)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.T.Lei,
Z.Shen,
P.Surana,
M.D.Routh,
C.C.Su,
Q.Zhang,
and
E.W.Yu
(2011).
Crystal structures of CmeR-bile acid complexes from Campylobacter jejuni.
|
| |
Protein Sci,
20,
712-723.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.M.Peters,
B.E.Brooks,
M.A.Schumacher,
R.A.Skurray,
R.G.Brennan,
and
M.H.Brown
(2011).
A single acidic residue can guide binding site selection but does not govern QacR cationic-drug affinity.
|
| |
PLoS One,
6,
e15974.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Wade
(2010).
MD recognition by MDR gene regulators.
|
| |
Curr Opin Struct Biol,
20,
489-496.
|
 |
|
|
|
|
 |
A.Hernández,
M.J.Maté,
P.C.Sánchez-Díaz,
A.Romero,
F.Rojo,
and
J.L.Martínez
(2009).
Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF.
|
| |
J Biol Chem,
284,
14428-14438.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.D.Routh,
C.C.Su,
Q.Zhang,
and
E.W.Yu
(2009).
Structures of AcrR and CmeR: insight into the mechanisms of transcriptional repression and multi-drug recognition in the TetR family of regulators.
|
| |
Biochim Biophys Acta,
1794,
844-851.
|
 |
|
|
|
|
 |
T.Eicher,
L.Brandstätter,
and
K.M.Pos
(2009).
Structural and functional aspects of the multidrug efflux pump AcrB.
|
| |
Biol Chem,
390,
693-699.
|
 |
|
|
|
|
 |
X.Li,
X.He,
B.Wang,
and
K.Merz
(2009).
Conformational variability of benzamidinium-based inhibitors.
|
| |
J Am Chem Soc,
131,
7742-7754.
|
 |
|
|
|
|
 |
X.Z.Li,
and
H.Nikaido
(2009).
Efflux-mediated drug resistance in bacteria: an update.
|
| |
Drugs,
69,
1555-1623.
|
 |
|
|
|
|
 |
C.J.Tsai,
Z.E.Sauna,
C.Kimchi-Sarfaty,
S.V.Ambudkar,
M.M.Gottesman,
and
R.Nussinov
(2008).
Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima.
|
| |
J Mol Biol,
383,
281-291.
|
 |
|
|
|
|
 |
J.Wu,
K.A.Hassan,
R.A.Skurray,
and
M.H.Brown
(2008).
Functional analyses reveal an important role for tyrosine residues in the staphylococcal multidrug efflux protein QacA.
|
| |
BMC Microbiol,
8,
147.
|
 |
|
|
|
|
 |
K.J.Newberry,
J.L.Huffman,
M.C.Miller,
N.Vazquez-Laslop,
A.A.Neyfakh,
and
R.G.Brennan
(2008).
Structures of BmrR-drug complexes reveal a rigid multidrug binding pocket and transcription activation through tyrosine expulsion.
|
| |
J Biol Chem,
283,
26795-26804.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.M.Peters,
J.T.Schuman,
R.A.Skurray,
M.H.Brown,
R.G.Brennan,
and
M.A.Schumacher
(2008).
QacR-cation recognition is mediated by a redundancy of residues capable of charge neutralization.
|
| |
Biochemistry,
47,
8122-8129.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
U.Okada,
K.Kondo,
T.Hayashi,
N.Watanabe,
M.Yao,
T.Tamura,
and
I.Tanaka
(2008).
Structural and functional analysis of the TetR-family transcriptional regulator SCO0332 from Streptomyces coelicolor.
|
| |
Acta Crystallogr D Biol Crystallogr,
64,
198-205.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.A.Hassan,
R.A.Skurray,
and
M.H.Brown
(2007).
Transmembrane helix 12 of the Staphylococcus aureus multidrug transporter QacA lines the bivalent cationic drug binding pocket.
|
| |
J Bacteriol,
189,
9131-9134.
|
 |
|
|
|
|
 |
K.D.Koclega,
M.Chruszcz,
M.D.Zimmerman,
M.Cymborowski,
E.Evdokimova,
and
W.Minor
(2007).
Crystal structure of a transcriptional regulator TM1030 from Thermotoga maritima solved by an unusual MAD experiment.
|
| |
J Struct Biol,
159,
424-432.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.A.Hassan,
M.Galea,
J.Wu,
B.A.Mitchell,
R.A.Skurray,
and
M.H.Brown
(2006).
Functional effects of intramembranous proline substitutions in the staphylococcal multidrug transporter QacA.
|
| |
FEMS Microbiol Lett,
263,
76-85.
|
 |
|
|
|
|
 |
E.W.Yu,
J.R.Aires,
G.McDermott,
and
H.Nikaido
(2005).
A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study.
|
| |
J Bacteriol,
187,
6804-6815.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.L.Ramos,
M.Martínez-Bueno,
A.J.Molina-Henares,
W.Terán,
K.Watanabe,
X.Zhang,
M.T.Gallegos,
R.Brennan,
and
R.Tobes
(2005).
The TetR family of transcriptional repressors.
|
| |
Microbiol Mol Biol Rev,
69,
326-356.
|
 |
|
|
|
|
 |
M.A.Schumacher,
M.C.Miller,
and
R.G.Brennan
(2004).
Structural mechanism of the simultaneous binding of two drugs to a multidrug-binding protein.
|
| |
EMBO J,
23,
2923-2930.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |